Yahoo
    HKSE - Delayed Quote HKD

    Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)

    2.340 -0.020 (-0.85%)
    At close: 4:08:07 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 1349.HK
    • Previous Close 2.360
    • Open 2.355
    • Bid 2.330 x --
    • Ask 2.345 x --
    • Day's Range 2.325 - 2.415
    • 52 Week Range 2.200 - 3.690
    • Volume 955,000
    • Avg. Volume 1,181,730
    • Market Cap (intraday) 2.441B
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) --
    • EPS (TTM) -0.130
    • Earnings Date (est.) --
    • Forward Dividend & Yield 0.03 (0.00%)
    • Ex-Dividend Date Jul 10, 2025
    • 1y Target Est --

    Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.

    www.fd-zj.com/DesktopModules/HT/chinese/home/Index.aspx

    876

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

    YTD Return

    1349.HK
    16.13%
    HANG SENG INDEX (^HSI)
    8.21%

    1-Year Return

    1349.HK
    30.15%
    HANG SENG INDEX (^HSI)
    10.06%

    3-Year Return

    1349.HK
    2.09%
    HANG SENG INDEX (^HSI)
    33.19%

    5-Year Return

    1349.HK
    31.91%
    HANG SENG INDEX (^HSI)
    5.99%

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -15.52%

    • Return on Assets (ttm)

      -2.88%

    • Return on Equity (ttm)

      -4.68%

    • Revenue (ttm)

      664.43M

    • Net Income Avi to Common (ttm)

      -103.09M

    • Diluted EPS (ttm)

      -0.130

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.27B

    • Total Debt/Equity (mrq)

      0.49%

    • Levered Free Cash Flow (ttm)

      177.22M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    1330.HK Dynagreen Environmental Protection Group Co., Ltd.
    6.650 +1.22%
    1302.HK LifeTech Scientific Corporation
    1.540 -1.91%
    1345.HK Shanghai Pioneer Holding Ltd
    1.960 +0.51%
    1375.HK Central China Securities Co., Ltd.
    1.435 -0.35%
    1385.HK Shanghai Fudan Microelectronics Group Company Limited
    21.100 -3.39%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: